Which is more useful in non-obese patients (BMI<30) undergoing tracheal intubation, T1% of the corrugator supercilii muscle, or effect site concentration of rocuronium calculated by the iPad application AnestAssist ?

Which is more useful in non-obese patients (BMI<30) undergoing tracheal intubation, T1% of the corrugator supercilii muscle, or effect site concentration of rocuronium calculated by the iPad application AnestAssist ? - Which is more useful in non-obese patients undergoing tracheal intubation, T1% of the corrugator supercilii muscle, or effect site concentration of rocuronium ?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012431

Enrollment

165

Registered

2013-11-28

Start date

2013-11-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases which require elective surgery under general anesthesia

Interventions

Patients who are given rocuronium 0.6mg/kg before tracheal intubation Patients who are given rocuronium 0.7mg/kg before tracheal intubation Patients who are given rocuronium 0.8mg/kg before tracheal i

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non-obese patients undergoing elective surgery under general anesthesia (BMI<30)

Exclusion criteria

Exclusion criteria: 1. When it is difficult to intubate, the patient is excluded. 2. When it is impossible to calibrate TOF-Watch, the patient is excluded. 3. When unexpected complications occur, the patient is excluded.

Design outcomes

Primary

Measure	Time frame
T1% of the corrugator supercilii muscle, effect site concentration of rocurronium calculated by software, and tracheal intubation condition	—

Secondary

Measure	Time frame
What patient characteristics affect tracheal intubation condition?	—

Countries

Japan

Contacts

Public ContactMASATO SATO

Keiyu Hospital Department of Anesthesiology

keiyumasui@gmail.com045-221-8181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Which is more useful in non-obese patients (BMI&lt;30) undergoing tracheal intubation, T1% of the corrugator supercilii muscle, or effect site concentration of rocuronium calculated by the iPad application AnestAssist ?